Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2005
09/22/2005US20050208056 Neoplasm specific antibodies and uses thereof
09/22/2005US20050208055 Monoclonal antibodies; hybridoma cell lines; for use in Western blot analysis, immunohistochemisty, protein purification; diagnosis of cancer and vitamin D metabolic conditions; drug screening
09/22/2005US20050208054 Screening protein kinase (Akt)/serine-threonine kinase modulators; regulating glucose transport
09/22/2005US20050208053 Administering very late antigen-4, antigen binding fragment thereof, soluble vascular cell adhesion molecule-1 polypeptide; chimera
09/22/2005US20050208051 Administering an antagonistic antibody immunoreactive with IL-1 epsilon for therapy of inflammatory and/or autoimmune disease selected from the group consisting of asthma, inflammatory bowel disease, psoriasis, and combinations thereof
09/22/2005US20050208050 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
09/22/2005US20050208049 Expanding CD4 + T cells; antiretroviral drug; induce active pathogen replication in cell latently infected with HIV and anti-pathogen drug
09/22/2005US20050208048 HLA-DR specific antibodies, compositions and methods
09/22/2005US20050208046 TWEAK receptor
09/22/2005US20050208045 Augment signaling of ligand of receptor serine kinase in a cell, inhibit formation of complexes between developmental oncoprotein and ligand on the surface of cell
09/22/2005US20050208044 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
09/22/2005US20050208043 Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
09/22/2005US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin
09/22/2005US20050208041 Variable domain framework regions from the heavy and light chains are unaltered from the human antibody or human antibody consensus framework; additional antibody modifications to decrease antigenicity of the antibody itself; autoimmune disorder
09/22/2005US20050208040 Polynucleotides and polypeptides encoded thereby
09/22/2005US20050208027 Methods and compositions for regeneration of aged tissues
09/22/2005US20050207977 targeted immunotherapy comprising administering an immunoglobulin molecule produced from an artificial proprotein, capable of binding to target antigens
09/22/2005US20050207975 administering monoclonal Tac-antibodies; anticarcinogenic agents; immunotherapy
09/22/2005US20050207974 antibodies, fragments or ligands that specifically binds to polypeptides or polynucleotides that are differentially expressed in vascular endothelial cells, conjugated to drugs or cytotoxic agents such as angiogenesis inhibitors or activators; treatment of vascular diseases; inhibiting tumor growth
09/22/2005DE102005013370A1 The test for a malignant disease, and especially prostate cancer, determines the concentration of transformed alpha2 macroglobulins for comparison with a healthy control group
09/22/2005DE102004010928A1 Enriching prokaryotic DNA from solution, useful e.g. for early diagnosis of bacterial infection, by treatment with protein that binds selectively to non-methylated CpG motifs then separating the complex formed
09/22/2005DE102004010050A1 Spezifische monoklonale und polyklonale Antikörper für Repinotan und dessen ringoffene Form Specific monoclonal and polyclonal antibodies for repinotan and its ring-open form
09/22/2005DE10160921B4 Verfahren zum Nachweis von Allergien und Verwendung eines Antikörpers zum Nachweis von Allergien A method for the detection of allergies and the use of an antibody for the detection of allergies
09/22/2005CA2560200A1 Cd44-targeting for reducing/preventing ischemia-reperfusion-injury
09/22/2005CA2559144A1 Estrogen receptor alpha splice variant er-.alpha.36
09/22/2005CA2559124A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof
09/22/2005CA2559069A1 Axon regeneration promoter
09/22/2005CA2559060A1 Phospholipases, nucleic acids encoding them and methods for making and using them
09/22/2005CA2558911A1 Process for producing polypeptides
09/22/2005CA2557374A1 Mutant proteins in the dna-binding domain of a trlomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna
09/22/2005CA2555541A1 Cd38 splice variant and uses thereof
09/22/2005CA2533878A1 Fluorinated carbohydrate conjugates
09/21/2005EP1577671A1 Diagnostic drugs for autoimmune diseases
09/21/2005EP1577391A1 Neutrokine alpha
09/21/2005EP1577383A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof
09/21/2005EP1577382A2 Detection of TSE infectivity
09/21/2005EP1576370A2 Methods of diagnosing and treating diabetes and insulin resistance
09/21/2005EP1576179A2 Methods and compositions for inducing apoptosis in cancer cells
09/21/2005EP1576172A2 Serum protein-associated target-specific ligands and identification method therefor
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576157A1 Fluorescent proteins from copepoda species and methods for using same
09/21/2005EP1576137A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1576119A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
09/21/2005EP1576108A2 Nitrilases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576105A2 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576101A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
09/21/2005EP1576100A2 Purified composition of bispecific molecules and methods of production
09/21/2005EP1576090A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/21/2005EP1576087A2 Method for detecting remote homologues and kinases identified with the method
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576014A1 Antibodies against pd-1 and uses therefor
09/21/2005EP1576013A2 Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13ra1)
09/21/2005EP1576012A1 Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographic strip
09/21/2005EP1576011A2 Inhibition of il-17 production
09/21/2005EP1576010A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
09/21/2005EP1576003A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
09/21/2005EP1576002A2 Peptide oligomers for use as hiv vaccines
09/21/2005EP1575997A2 Phosphospecific pak antibodies and diagnostic kits
09/21/2005EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
09/21/2005EP1575917A2 Hemipteran muscarinic receptor
09/21/2005EP1575672A2 Use of cd137 antagonists for the treatment of tumors
09/21/2005EP1575615A1 Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same
09/21/2005EP1575607A1 Vanilloid receptor-2 ligands for treating anxiety or depression
09/21/2005EP1575602A2 Methods for treating cancer using porimin as a target
09/21/2005EP1575571A2 Compositions and methods for the diagnosis and treatment of tumor
09/21/2005EP1575545A2 Affinity proteins for controlled application of cosmetic substances
09/21/2005EP1575525A2 Cell surface tropomyosin as a target of angiogenesis inhibition
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575522A2 Methods for treating pain by administering a nerve growth factor antagonist and an opioid analgesic and compositions containing the same
09/21/2005EP1575518A2 Compositions, organisms and methodologies employing a novel human kinase
09/21/2005EP1575517A2 Anti-ngf antibodies and methods using same
09/21/2005EP1575516A2 Chimeric and humanized antibodies to alpha5 beta1 integrin that modulate angiogenesis
09/21/2005EP1575514A2 Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders
09/21/2005EP1575509A2 Epha2 agonistic monoclonal antibodies and methods of use thereof
09/21/2005EP1575508A2 Compositions and methods for the intracellular delivery of antibodies
09/21/2005EP1575500A2 Mesothelin vaccines and model systems
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575497A2 Novel composition and methods for the treatment of psoriasis
09/21/2005EP1575491A2 Treatment of renal carcinoma using antibodies against the egfr
09/21/2005EP1575484A2 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1575416A2 Methods of diagnosing and treating pre-eclampsia or eclampsia
09/21/2005EP1478923A4 Assay for anti-ingap antibodies
09/21/2005EP1263446B1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
09/21/2005EP1212082A4 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
09/21/2005EP0974057B1 Methods to detect hk2 polypeptides
09/21/2005EP0793721B1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005EP0752853B1 Human brain phosphodiesterase
09/21/2005CN1672160A Generation and selection of protein library in silico
09/21/2005CN1671844A Antigenic neisserial peptides
09/21/2005CN1671842A Method of promoting homologous recombination of somatic cells and method of constructing specific antibody
09/21/2005CN1671837A Neutralizing human anti-IGFR antibody
09/21/2005CN1671741A Buffered formulations for concentrating antibodies and methods of use thereof
09/21/2005CN1671722A Campylobacter glycans and glycopeptides
09/21/2005CN1671417A Anti-myelin associated glycoprotein (MAG) antibodies
09/21/2005CN1671416A Super humanized antibodies
09/21/2005CN1671415A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
1 ... 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 ... 1494